Tarsus Pharmaceuticals Inc (TARS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 245,363 | 175,010 | 171,332 | 183,801 | 176,735 |
| Marketable Securities | N/A | 291 | 483 | N/A | N/A |
| Receivables | 620 | 323 | 92 | 139 | 20,157 |
| TOTAL | $250,283 | $178,755 | $175,952 | $187,088 | $200,904 |
| Non-Current Assets | |||||
| PPE Net | 963 | 915 | 755 | 519 | 481 |
| Investments And Advances | 169 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 1,413 | 1,813 | 2,200 | 2,805 | 2,065 |
| TOTAL | $2,545 | $2,728 | $2,955 | $3,324 | $2,546 |
| Total Assets | $252,828 | $181,483 | $178,907 | $190,412 | $203,450 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,938 | 10,805 | 8,680 | 8,119 | 8,985 |
| TOTAL | $11,718 | $12,610 | $11,478 | $10,365 | $10,455 |
| Non-Current Liabilities | |||||
| Long Term Debt | 19,262 | 19,180 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 343 | 496 | 699 | 905 | 524 |
| TOTAL | $19,605 | $19,676 | $699 | $905 | $524 |
| Total Liabilities | $31,323 | $32,286 | $12,177 | $11,270 | $10,979 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 26,658 | 20,728 | 20,709 | 20,677 | 20,574 |
| Common Shares | 5 | 4 | 4 | 4 | 4 |
| Retained earnings | -72,653 | -66,910 | -46,672 | -31,821 | -16,124 |
| TOTAL | $221,505 | $149,197 | $166,730 | $179,142 | $192,471 |
| Total Liabilities And Equity | $252,828 | $181,483 | $178,907 | $190,412 | $203,450 |